Difference between revisions of "Team:NCTU Formosa"

Line 15: Line 15:
 
         position:relative;
 
         position:relative;
 
         width:100%;
 
         width:100%;
 +
}
 +
.div1-1{
 +
        background:rgb(42,189,243);
 +
        height:100vh;
 +
        position:relative;
 +
        width:90%;
 +
margin:0px auto;
 
}
 
}
 
         .div2{
 
         .div2{
Line 173: Line 180:
  
 
<div class="div1">
 
<div class="div1">
−
 
+
<div class="div1-1">
 
<video autoplay id="bgvid">
 
<video autoplay id="bgvid">
 
<source src="https://static.igem.org/mediawiki/2015/9/9b/Nctu_formosa_homepage_video.mp4" type="video/mp4">
 
<source src="https://static.igem.org/mediawiki/2015/9/9b/Nctu_formosa_homepage_video.mp4" type="video/mp4">
 
</source>
 
</source>
 
         </video>
 
         </video>
 +
</div>
 
</div>
 
</div>
 
      
 
      

Revision as of 21:57, 17 September 2015

The only thing we can detect is everything.

Who are we

NCTU_Formosa created an organization-APOllO, which stands for Almighty Probe of scFv Organization. APOllO devoted to developing detection technology by utilizing antibodies. In 2015, We cooperated with iGEM with Synthetic Biology to develop a brand new detection platform.

What's new

APOllO E.Cotector:
Our organization create a customized scFv detection platform by co-transforming any desired plasmid. ScFv utilizing antigen-antibody interaction can act as probes. Our E.Cotector can therefore have the function of a detector.

What do we care

In 2015, we focus on helping doctors select the appropriate candidates for monoclonal-antibody targeted drug for patient's treatment in a more inexpensive way. If the cost for diagnosis decreases, more patients can afford it. Therefore, more patients can be prescribed and treated, lowering the mortality rate of cancer.